Ponaxen 45mg (Ponatinib Tablet) 45mg

Ponaxen 45mg tablets contain ponatinib, a prescription medication used in certain blood cancer treatments. Ponaxen 45mg is supplied in packs of 30 tablets for oral use. Ponatinib belongs to the tyrosine kinase inhibitor class and is manufactured by Everest Pharmaceuticals.

Strength

45mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Everest Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ponatinib, the active ingredient in Ponaxen 45mg, is used to treat certain types of leukemia, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Patients often ask, 'what is Ponaxen 45mg used for?' when considering treatment options for blood cancers. It is prescribed when other treatments have not been effective or suitable.

Side Effects

Ponaxen 45mg works by blocking signals that promote cancer cell growth. Many patients notice changes in energy levels and blood cell counts during treatment. Some experience mild gastrointestinal effects such as nausea or stomach discomfort. These effects vary by individual and should be discussed with a healthcare provider.

Precautions & Warnings

Ponaxen 45mg should be stored at room temperature away from moisture and heat. Keep out of reach of children and pets. Patients should inform their doctor of all current medications and health conditions before starting ponatinib. Regular blood tests are typically required during treatment to monitor safety.

Avoid Interactions

Ponaxen 45mg may interact with other drugs that affect liver enzymes, such as certain antibiotics or antifungals. Grapefruit products can increase ponatinib levels in the blood. Patients should avoid grapefruit while taking this medication. Alcohol use may worsen side effects like nausea or dizziness.

References

Frequently Asked Questions

Ponaxen 45mg is used to treat certain types of leukemia, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Store Ponaxen 45mg at room temperature, away from moisture, heat, and direct light. Keep the medication in its original packaging.

No, grapefruit and grapefruit juice should be avoided while taking Ponaxen 45mg as they may increase the risk of side effects.

Ponaxen 45mg is a targeted therapy known as a tyrosine kinase inhibitor, not a traditional chemotherapy agent.

Common side effects may include nausea, fatigue, skin rash, and changes in blood cell counts. Always report persistent effects to your doctor.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.